Oklahoma Metropolis Thunder guard Nikola Subject has begun chemotherapy therapy after being recognized with testicular most cancers, basic supervisor Sam Presti advised reporters Thursday.
Presti mentioned medical doctors are “extraordinarily optimistic” in regards to the long-term outlook for Subject, the No. 12 choose within the 2024 draft who sat out final season whereas recovering from a torn ACL.
Subject underwent a process in early October at MD Anderson Most cancers Middle in Houston to get a biopsy. After receiving the outcomes, he requested the Thunder to not publicly reveal his analysis till he had began the chemotherapy remedies, Presti mentioned.
Subject has been capable of work out whereas starting chemotherapy, however Presti mentioned there isn’t a timetable for the 20-year-old Serbian guard to make his NBA debut.
“Our solely expectations for him are to deal with this,” Presti mentioned. “That is his most necessary precedence. He’ll be again enjoying basketball when he is capable of, however we’re not placing any time size or expectations on that clearly. He has our complete assist, encouragement and love.”

